Price $1.47 |
Market Cap
28.7M
|
Sector Health Care |
Div. Growth
-
|
P/E
-
|
P/B
0.78
|
P/S
0.72
|
Dividend %
-
|
P/CF
591.9
|
P/FCF
3.0
|
Op. Cash Flow
10.1K
|
FCF
0.6
|
Op. Margin
-10.10%
|
Net Margin
-4.40%
|
ROE
-4.80%
|
ROI
-11.00%
|
ROA
-2.00%
|
EPS Growth
76.00%
|
Current Ratio
1.6
|
Debt/Equity
44.60%
|
Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
---|---|---|---|---|---|
ZimVie Inc (ZIMV) | $21.82 | - | - | 197.4M | Strong Buy |
Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
Myomo Inc (MYO) | $5.03 | - | - | 35.8M | Strong Buy |
Marizyme Inc (MRZM) | $0.05 | - | - | 8.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More